CytoDyn Inc. Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details) $ in Thousands					6 Months Ended
Commitments and Contingencies (Details) $ in Thousands	Dec. 20, 2022 item	Aug. 18, 2021 lawsuit	Jun. 25, 2021 lawsuit	Jun. 04, 2021 lawsuit	Nov. 30, 2023 USD ($)	Jan. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Shareholder Derivative Lawsuits
Commitments and Contingencies
Number of additional shareholder derivative lawsuits \| lawsuit		2	2
Consolidated number of lawsuits \| lawsuit				3
Securities and Exchange Commission and Department of Justice Investigations \| Mr. Pourhassan
Commitments and Contingencies
Number of conspiracy charges	1
Number of security fraud charges	4
Number of wire fraud charges	3
Number of insider trading charges	3
Securities and Exchange Commission and Department of Justice Investigations \| Kazem Kazempour
Commitments and Contingencies
Number of conspiracy charges	1
Number of security fraud charges	3
Number of wire fraud charges	2
Number of insider trading charges	1
Samsung BioLogics Co., Ltd. ("Samsung")
Commitments and Contingencies
Forecast period					3 years
Amount of material breach of' Master Services and Project Specific Agreements \| $							$ 13,500
Additional Contractual Obligation \| $						$ 22,800
Past due balance \| $					$ 232,788
Accounts Payable \| Samsung BioLogics Co., Ltd. ("Samsung")
Commitments and Contingencies
Past due balance \| $					$ 32,000